On June 23, YOCO Optics made an official announcement stating that the company had successfully acquired a 20% equity stake in Jiangfeng Biology by investing 160 million yuan. Concurrently, its affiliated entity, Dongyuan Venture Capital, purchased a 2.4875% stake for 19.9 million yuan. Together, these acquisitions amount to a combined 22.4875% stake, with the industrial and commercial registration changes now duly completed.

The valuation of Jiangfeng Biology, which served as the basis for this transaction, was set at 800 million yuan. The investment plan received approval from the board of directors on April 22 and subsequently from the shareholders' meeting on May 15. Following these approvals, the 'Equity Transfer Framework Agreement' and 'Shareholders Agreement' were formally signed on June 4.

With the registration change now finalized, YOCO Optics has ascended to the position of the second-largest shareholder in Jiangfeng Biology. This strategic investment is aimed at bolstering the company's industrial footprint in the realms of high-end optical microscopes and medical optics.